Study of the interaction between polymorphisms of URAT1 gene and HUA in Uyghur
LI Rui1 QIN Liyan2 ZHANG Bei1 CHEN Wujin1 SUN Yuping1
1.School of Basic Medical Sciences, Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi 830011, China;
2.The Sixth Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi 830002, China
Abstract：Objective To explore the interaction between human urate transporter 1 (URAT1) gene rs3825018, rs505802 and rs524023 gene polymorphisms and Uygur hyperuricemia (HUA). Methods A total of 2340 Uygur subjects who took part in physical examination in the health management center of an Affiliated Hospital in Urumqi from November 2014 to December 2016 were selected as subjects and divided into HUA group (n = 986) and control group (n = 1354) according to the level of uric acid. The body height, weight, waist and hip circumference, blood pressure and other general indicators were measured. The venous blood samples were collected after fasting for 12 hours. The biochemical indicators such as serum uric acid, creatinine, glucose, total cholesterol and triacylglycerol, and the polymorphisms of URAT1 gene rs3825018, rs505802 and rs524023 loci were detected. Results The distribution of alleles and genotype frequencies of rs3825018, rs505802 and rs524023 in URAT1 gene were not significantly different between HUA group and control group (P > 0.05). Genetic model analysis found that rs3825018, rs505802 and rs524023 were not significantly associated with Uyghur HUA in all three genetic models (95% CI across 1), regardless of age or gender. The results of the interaction showed that there was a negative interaction between the Uygur females carrying the rs505802 locus mutation in the additive model (S = -0.146, P < 0.05). Conclusion The mutations of rs3825018, rs505802 and rs524023 in URAT1 gene may not affect the susceptibility of Uygur HUA. The risk of HUA may be reduced to some extent by carrying rs505802 mutation in Uygur women.
李瑞1 秦丽岩2 张蓓1 陈邬锦1 孙玉萍1. URAT1基因多态性与维吾尔族高尿酸血症的交互作用研究[J]. 中国医药导报, 2019, 16(7): 4-6,14.
LI Rui1 QIN Liyan2 ZHANG Bei1 CHEN Wujin1 SUN Yuping1. Study of the interaction between polymorphisms of URAT1 gene and HUA in Uyghur. 中国医药导报, 2019, 16(7): 4-6,14.
[1] Setyaningsih WAW，Arfian N，Suryadi E，et al. Hyperuricemia Induces Wnt5a/Ror2 Gene Expression，Epithelial-Mesenchymal Transition，and Kidney Tubular Injury in Mice [J]. Iran J Med Sci，2018，43（2）：164-173.
[2] Eleftheriadis T，Golphinopoulos S，Pissas G，et al. Asympto-matic hyperuricemia and chronic kidney disease：Narrative review of a treatment controversial [J]. J Adv Res，2017，8（5）：555-560.
[3] Tan PK，Liu S，Gunic E，et al. Discovery and characterization of verinurad，a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout [J]. Sci Rep，2017，7（1）：665.
[4] Ma Y，Cao H，Li Z，et al. A Novel Multi-Epitope Vaccine Based on Urate Transporter 1 Alleviates Streptozotocin-Induced Diabetes by Producing Anti-URAT1 Antibody and an Immunomodulatory Effect in C57BL/6J Mice [J]. Int J Mol Sci，2017，18（10）： E2137.
[5] 聚宝.高尿酸血症的诊断标准及治疗[J].现代诊断与治疗，1997，8（4）：199-200.
[6] Dong H，Xu Y，Zhang X，et al. Visceral adiposity index is strongly associated with hyperuricemia independently of metabolic healthand obesity phenotypes [J]. Sci Rep，2017， 7（1）：8822.
[7] 余家会，张蓓，古丽尼扎·哈力阿克帕尔，等.高尿酸血症与脂代谢紊乱的关系及其民族异质性分析[J].国际检验医学杂志，2015，36（2）：145-147.
[8] 王婷婷，马琦，马艳，等.新疆维吾尔族代谢综合征危险因素与尿酸的关系研究[J].中华内分泌代谢杂志，2014， 30（9）：755-759.
[9] 蔡雯，翁迪华，林玉婷，等.新疆维吾尔族、汉族成人高尿酸血症患病情况及相关危险因素分析[J].流行病学与预防保健，2016，32（8）：1086-1089.
[10] Palazzuoli A，Ruocco G，De Vivo O，et al. Prevalence of Hyperuricemia in Patients With Acute Heart Failure With Either Reduced or Preserved Ejection Fraction [J]. Am J Cardiol，2017，120（7）：1146-1150.
[11] Li N，Zhang S，Li W，et al. Prevalence of hyperuricemia and its related risk factors among preschool children from China [J]. Sci Rep，2017，7（1）：9448.
[12] 许瑜佳，陈士芳.痛风发病年龄特征及降尿酸治疗对内皮功能的影响[J].中国现代医生，2017，55（28）：8-11.
[13] 朱丹，青玉凤，李青，等.我国川东北地区男性原发性痛风患者中不同原因高尿酸血症者危险因素及临床特点分析[J].成都医学院学报，2018，13（1）：45-49.
[14] 高景然，林可意，娜佳.2型糖尿病合并高尿酸血症对高血压患病风险的影响分析[J].中国医药科学，2018，8（3）：89-92.
[15] 陈说，张帆，彭卫群，等.健康体检人群体脂率与代谢指标的相关性研究[J].中国医药科学，2018，8（3）：23-25.
[16] Stiburkova B，Sebesta I，Ichida K，et al. Novel allelic variants and evidence for a prevalent mutation in URAT1 causing renal hypouricemia：biochemical，genetics and functional analysis [J]. Eur J Hum Genet，2013，21（10）：1067-1073.
[17] Mancikova A，Krylov V，Hurba O，et al. Functional analysis of novel allelic variants in URAT1and GLUT9 causing renal hypouricemia type 1 and 2 [J]. Clin Exp Nephrol，2016，20（4）：578-584.
[18] Cho SK，Kim S，Chung JY，et al. Discovery of URAT1 SNPs and association between serum uric acid levels and URAT1 [J]. BMJ Open，2015，5（11）：e 009 360.
[19] 韩琳，于清，胡东明，等.中国汉族人尿酸盐转运蛋白1基因启动子区多态性与原发性高尿酸血症的关联研究[J].中华内分泌代谢杂志，2012，28（1）：36-39.
2019, Vol. 16 
京公网安备 11010502046598号